Establishment Labs Holdings Inc (NASDAQ:ESTA) Major Shareholder Acquires $66,450.00 in Stock

Share on StockTwits

Establishment Labs Holdings Inc (NASDAQ:ESTA) major shareholder Jw Asset Management, Llc acquired 3,000 shares of the stock in a transaction on Monday, August 12th. The stock was bought at an average cost of $22.15 per share, with a total value of $66,450.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Jw Asset Management, Llc also recently made the following trade(s):

  • On Wednesday, July 31st, Jw Asset Management, Llc acquired 1,500 shares of Establishment Labs stock. The stock was bought at an average cost of $25.31 per share, with a total value of $37,965.00.
  • On Monday, July 29th, Jw Asset Management, Llc acquired 2,500 shares of Establishment Labs stock. The stock was bought at an average cost of $25.58 per share, with a total value of $63,950.00.

Establishment Labs stock opened at $21.94 on Thursday. The stock has a market cap of $472.47 million and a PE ratio of -19.59. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.10 and a current ratio of 5.54. Establishment Labs Holdings Inc has a 1 year low of $20.05 and a 1 year high of $30.70. The firm has a 50-day moving average of $22.90.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.52) by $0.08. The company had revenue of $21.68 million during the quarter, compared to analysts’ expectations of $20.10 million. Establishment Labs had a negative net margin of 37.74% and a negative return on equity of 68.22%. On average, research analysts predict that Establishment Labs Holdings Inc will post -1.94 earnings per share for the current year.

Large investors have recently bought and sold shares of the company. Vanguard Group Inc. bought a new stake in shares of Establishment Labs in the 2nd quarter valued at about $349,000. Wells Fargo & Company MN bought a new stake in shares of Establishment Labs in the 2nd quarter valued at about $479,000. Tower Research Capital LLC TRC raised its holdings in shares of Establishment Labs by 257.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,350 shares of the company’s stock valued at $30,000 after purchasing an additional 972 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Establishment Labs by 96.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 13,014 shares of the company’s stock valued at $273,000 after purchasing an additional 6,386 shares in the last quarter. Finally, BBR Partners LLC bought a new stake in shares of Establishment Labs in the 2nd quarter valued at about $445,000. Institutional investors and hedge funds own 25.86% of the company’s stock.

Several research firms have issued reports on ESTA. Stephens began coverage on shares of Establishment Labs in a research report on Thursday, June 6th. They issued an “overweight” rating and a $37.00 price objective for the company. ValuEngine raised shares of Establishment Labs from a “hold” rating to a “buy” rating in a research report on Monday, July 29th. Wells Fargo & Co set a $29.00 price objective on shares of Establishment Labs and gave the company a “buy” rating in a research report on Friday, July 12th. Finally, BTIG Research reissued a “buy” rating and issued a $40.00 price objective on shares of Establishment Labs in a research report on Thursday, May 16th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $35.33.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.

Featured Article: What is the Dividend Aristocrat Index?

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
$1.31 EPS Expected for Microchip Technology Inc.  This Quarter
$1.31 EPS Expected for Microchip Technology Inc. This Quarter
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
-$0.63 Earnings Per Share Expected for Instructure Inc  This Quarter
-$0.63 Earnings Per Share Expected for Instructure Inc This Quarter


© 2006-2019 Ticker Report